Furthermore, the risk of avascular necrosis (AVN) after Hb treatment was reduced from 35% to 13% with a hip spica and from 5% [10] to 2.8% in the YiQiang et al. control group. The gene discussed is GSTM1; the disease is avascular necrosis.